Enfermedad de Chagas: afección cardiaca

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Evaluación Del Tratamiento Antihipertensivo En Pacientes Diabéticos Hipertensos: Impacto De La Enfermedad Isquémica Cardiaca

www.pharmacypractice.org (ISSN: 1886-3655) 40 ABSTRACT Macrovascular complications are common in diabetic hypertensive patients. Appropriate antihypertensive therapy and tight blood pressure control are believed to prevent or delay such complication. Objective: To evaluate utilization patterns of antihypertensive agents and blood pressure (BP) control among diabetic hypertensive patients with a...

متن کامل

Chagas disease and globalization of the Amazon La enfermedad de Chagas y la globalización de la Amazonia

The increasing number of autochthonous cases of Chagas disease in the Amazon since the 1970s has led to fear that the disease may become a new public health problem in the region. This transformation in the disease’s epidemiological pattern in the Amazon can be explained by environmental and social changes in the last 30 years. The current article draws on the sociological theory of perverse ef...

متن کامل

Past and Present of Chagas Disease in Northern Chile* Pasado Y Presente De La Enfermedad De Chagas En El Norte De Chile

Contemporary understandings of the epidemiology of Chagas disease as well as it’s clinical features, together with knowledge of the insect vectors and genotypes of the causal agent Trypanosoma cruzi are important pieces of information for comparisons with cases in the past. Evidence indicates that 4,000 years ago in northern Chile cases displaying digestive symptoms or ‘megacolon’ were frequent...

متن کامل

Terapia de resincronización cardiaca. Indicaciones y contraindicaciones

Progress in medical therapy wouldn’t be possible without the contribution of the scientific community. Several randomized controlled trials have led to our current guidelines. Specifically, COMPANION and CARE-HF trials involved a turning point for cardiac resynchronization therapy, which became well recognized for the treatment of heart failure patients with QRS 120 ms, ejection fraction 35%, a...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Revista Medica Sinergia

سال: 2019

ISSN: 2215-5279,2215-4523

DOI: 10.31434/rms.v4i5.212